While Lenacapavir na ogbonge drug to prevent HIV especially among high risk population, e no dey safe for pregnant women sake ...

A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.

Weekly injectable buprenorphine is more effective than daily doses for treating opioid use disorder in pregnancy, with higher ...

In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder ...

The director general of the National Agency for the Control of AIDS,Temitope Ilori,has clarified that the newly introduced ...

The Director-General of the National Agency for the Control of AIDS, Temitope Ilori, has clarified that the newly introduced long-acting HIV prevention injection, Lenacapavir (LenPrEP), is not ...